Type of Chromatin Seen to Stop ‘Jumping Genes’ from Doing Harm, as in Hemophilia
New research suggests that the main developmental role of heterochromatin, a form of dense DNA found in chromosomes, is to suppress virus-like DNA…
Articles by Timea Polgar
Antibody Emicizumab Good for Patients with Hemophilia A, Phase 1 Trial Reveals
Chugai Pharmaceutical recently published data of a Phase I clinical study on the antibody emicizumab. The study, “Factor VIII–Mimetic…
Companies Partner for Faster, Long-acting Hemophilia Treatment
Catalyst Biosciences, developers of protease therapeutics for serious hemostasis and anti-complement conditions, and CMC ICOS Biologics, Inc., which manufactures therapeutic proteins,…